Decreased density of the platelet serotonin transporter in pathological gamblers

Neuropsychobiology

Volumn 57, Issue 1-2, 2008, Pages 38-43

  Marazziti, Donatella ^a   Golia, Francesca ^a   Picchetti, Michela ^a   Pioli, Ellena ^b   Mannari, Patrizia ^b   Lenzi, Francesco ^a   Conversano, Ciro ^a   Carmassi, Claudia ^a   Catena Dell'Osso, Mario ^a   Consoli, Giorgio ^a   Baroni, Stefano ^a   Giannaccini, Gino ^a   Zanda, Giuseppe ^b   Dell'Osso, Liliana ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Azienda USL 2   (Italy)

Author keywords

3H Paroxetine binding; Pathological gambling; Platelets; Serotonin; Serotonin transporter

Indexed keywords

PAROXETINE; SEROTONIN TRANSPORTER;

ADULT; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DISSOCIATION CONSTANT; FEMALE; HUMAN; MALE; MEMBRANE BINDING; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; THROMBOCYTE MEMBRANE;

ADULT; BINDING SITES; BLOOD PLATELETS; CELL COUNT; DEMOGRAPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GAMBLING; HUMANS; IMPULSE CONTROL DISORDERS; MALE; PAROXETINE; PLATELET MEMBRANE GLYCOPROTEINS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS;

EID: 45549095925     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000129665     Document Type: Article

References (59)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
2. Volberg RA: The prevalence and demographics of pathological gamblers: implications for public health. Am J Public Health 1994;84:237-241.
3. Pietrzak RH, Ladd GT, Petry NM: Disordered gambling in adolescents: epidemiology, diagnosis, and treatment. Paediatr Drugs 2003;5:583-595.
4. Lynch WJ, Maciejewski PK, Potenza MN: Psychiatric correlates of gambling in adolescents and young adults grouped by age at gambling onset. Arch Gen Psychiatry 2004;61:1116-1122.
5. Lesieur H, Blume SB, Zoppa RM: Alcoholism, drug abuse and gambling. Alcohol Clin Exp Res 1986;10:33-38.
6. Browne BA, Brown DJ: Predictors of lottery gambling among American college students. J Soc Psychol 1994;134:339-347.
7. Zeitlin H: Children with alcohol misusing parents. Br Med Bull 1994;50:139-151.
8. Dannon P, Sason M, Shalgi B, Tusan L, Sapir Y, Kotler M: Comorbid psychiatric symptoms in pathological gamblers: anxiety, depression and substance abuse. Harefuah 2004;143:643-695.
9. Comings DE: The molecular genetics of pathological gambling. CNS Spectr 1998;3:20-37.
10. Bechara A, Damasio AR, Damasio H, Anderson SW: Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 1994;50:7-15.
11. Fellows LK, Farah MJ: Different underlying impairments in decision-making following ventromedial and dorsolateral frontal lobe damage in humans. Cereb Cortex 2005;15:58-63.
12. Wiederkehr S, Barat M, Dehail P, de Seze M, Lozes-Boudillon S, Giroire JM: Decision making and executive function in severe traumatic brain injured patients: validation of a decision-making task and correlated features. Rev Neurol 2005;161:201-210.
13. Grant JE, Kim SW, Odlaug BL: N-Acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biol Psychiatry 2007;62:652-657.
14. Nordin C, Sjodin I: CSF cholecystokinin, gamma-aminobutyric acid and neuropeptide Y in pathological gamblers and healthy controls. J Neural Transm 2007;114:499-503.
15. Coccaro EF, Kavoussi RJ, Sheline YI, Lish JD, Csernansky JC: Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelets. Arch Gen Psychiatry 1996;53:531-536.
16. Siever L, Trestman RL: The serotonin system and aggressive personality disorder. Int Clin Psychopharmacol 1993;2:33-39.
17. Clark L, Roiser JP, Cools R, Rubinsztein DC, Sahakian BJ, Robbins TW: Stop signal response inhibition is not modulated by tryptophan depletion or the serotonin transporter polymorphism in healthy volunteers: implications for the 5-HT theory of impulsivity. Psychopharmacology 2005;182:570-578.
18. Ryding E, Ahnlide JA, Lindström M, Rosén I, Träskman-Bendz L: Regional brain serotonin and dopamine transporter binding capacity in suicide attempters relate to impulsiveness and mental energy. Psychiatry Res 2006;148:195-203.
19. Oreland L: Platelet monoamine oxidase, personality and alcoholism: the rise, fall and resurrection. Neurotoxicology 2004;25:79-89.
20. Carrasco JL, Saiz-Ruiz J, Hollander E, Cesar J, Lopez-Ibor JJ Jr: Low platelet monoamine oxidase activity in pathological gambling. Acta Psychiatr Scand 1994;90:427-431.
21. Blanco C, Orensanz-Munoz L, Blanco-Jerez C, Saiz-Ruiz J: Pathological gambling and platelet MAO activity: a psychobiological study. Am J Psychiatry 1996;153:119-121.
22. Paaver M, Nordquist N, Parik J, Harro M, Oreland L, Harro J: Platelet MAO activity and the 5-HTT gene promoter polymorphism are associated with impulsivity and cognitive style in visual information processing. Psychopharmacology 2007;194:545-554.
23. De Caria C, Begaz T, Hollander E: Serotonergic and noradrenergic function in pathological gambling. CNS Spectr 1998;3:38-47.
24. Pallanti S, Bernardi S, Quercioli L, DeCaria C, Hollander E: Serotonin dysfunction in pathological gamblers: increased prolactin response to oral m-CPP versus placebo. CNS Spectr 2006;11:956-964.
25. Zohar J, Insel TR: Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment and pathophysiology. Biol Psychiatry 1987;22:667-687.
26. Hollander E: Obsessive-Compulsive Related Disorders. Washington, American Psychiatric Press, 1993.
27. Nordin C, Sjödin I: CSF monoamine patterns in pathological gamblers and healthy controls. J Psychiatr Res 2006;40:454-459.
28. Stahl SM: The human platelet: a diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders. Arch Gen Psychiatry 1977;34:509-516.
29. Lesch KP, Wolozin BL, Murphy DL, Riederer P: Primary structure of the human platelet serotonin uptake: identity with the brain serotonin transporter. J Neurochem 1993;60:2319-2322.
30. 123I]-ADAM SPECT and serotonergic measurements in platelets. Neurosci Lett 2006;406:153-158.
31. Amara SG, Kuhar MJ: Neurotransmitter transporter: recent progress. Annu Rev Neurosci 1993;16:73-93.
32. Blakely RD, Felice L, Hartzell H: Molecular physiology of norepinephrine and serotonin transporters. J Exp Biol 1994;196:263-281.
33. Rudnick G: Serotonin transporters: structure and function. J Membr Biol 2006;213:101-110.
34. Slotkin TA, McCook EC, Ritchie JC, Carroll BJ, Seidler FJ: Serotonin transporter expression in rat brain regions and blood platelets: aging and glucocorticoid effects. Biol Psychiatry 1997;41:172-183.
35. Zalsman G, Anderson GM, Peskin M, Frisch A, King RA, Vekslerchik M, Sommerfeld E, Michaelovsky E, Sher L, Weizman A, Apter A: Relationships between serotonin transporter promoter polymorphism, platelet serotonin transporter binding and clinical phenotype in suicidal and non-suicidal adolescent inpatients. J Neural Transm 2005;112:309-315.
36. Marazziti D, Rossi A, Gemignani A, Giannaccini G, Pfanner C, Milanfranchi A, Presta S, Lucacchini A, Cassano GB: Decreased platelet 3H-paroxetine binding in obsessive-compulsive patients. Neuropsychobiology 1996;34:184-187.
37. Marazziti D, Dell'Osso L, Rossi A, Masala I, Baroni S, Armani A, Giannaccini G, Di Nasso E, Lucacchini A, Cassano GB: Decreased platelet [3H]-paroxetine binding sites in suicide attempters. Psychiatry Res 2001;103:125-131.
38. Marazziti D, Akiskal HS, Rossi A, Cassano GB: Alteration of the platelet serotonin transporter in romantic love. Psychol Med 1999;29:741-745.
39. Marazziti D, Rucci P, Di Nasso E, Masala I, Baroni S, Rossi A, Giannaccini G, Mengali F, Lucacchini A: Jealousy and subthreshold psychopathology: a serotonergic link. Neuropsychobiology 2003;47:12-16.
40. Mazzanti CM, Lappalainen J, Long JC, Bengel D, Naukkarinen H, Eggert M, Virkkunen M, Linnoila M, Goldman D: Role of the serotonin transporter promoter polymorphism in anxiety-related traits. Arch Gen Psychiatry 1998;55:936-940.
41. Brocke B, Armbruster D, Muller J, Hensch T, Jacob CP, Lesch KP, Kirschbaum C, Strobel A: Serotonin transporter gene variation impacts innate fear processing: acoustic startle response and emotional startle. Mol Psychiatry 2006;11:1106-1112.
42. Lesch KP: Linking emotion to the social brain: the role of the serotonin transporter in human social behaviour. EMBO Rep 2007;8:S24-S29.
43. Serretti A, Cusin C, Rausch JL, Bondy B, Smeraldi E: Pooling pharmacogenetic studies on the serotonin transporter: a megaanalysis. Psychiatry Res 2006;145:61-65.
44. Moreno I, Saiz-Ruiz JY, Lopez-Ibor JJ: Serotonin and gambling dependence. Hum Psychopharmacol 1991;6:S9-S12.
45. Rotondo A, Giannaccini G, Betti L, Chiellini G, Marazziti D, Martini C, Lucacchini A, Cassano GB: The serotonin transporter from human brain: purification and partial characterization. Neurochem Int 1996;28:299-307.
46. 3Himipramine to human platelet membranes. Eur J Pharmacol 1983;96:303-309.
47. Mann CD, Hrdina PD: Sodium dependence of [3H]-paroxetine binding and 5-[3H] hydroxytryptamine uptake in rat diencephalon. J Neurochem 1992;59:1856-1861.
48. Jurado N, Torner C, Heinze G, López G, Mendoza-Sotelo J, Lazo-Langner A, Moreno J: Methodologic pitfalls in measurement of 5-hydroxytriptamine uptake transporters in human platelets by [3H]-paroxetine binding assay. Arch Med Res 2003;34:422-427.
49. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSMIV Axis I Disorders: Patient Edition (SCID-I P, Version 2.0, 4 97 revision). New York, Biometrics Research, New York State Psychiatric Institute, 1997.
50. Lesieur HR, Blume SB: The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry 1987;144:1184-1188.
51. Peterson GL: A simplification of the protein assay method that is more generally applicable. Anal Biochem 1977;83:346-356.
52. McPherson GA: Kinetic, EBDA, Ligand, Lowry: A Collection of Radioligand Binding Analysis Programs. Cambridge, Biosoft, 1985.
53. Nie NH, Hull CH, Steinbrenner K, Bent DH: Statistical Package for the Social Science (SPSS), ed 4. New York, McGraw-Hill, 1998.
54. Marazziti D, Rossi A, Palego L, Barsanti A, Carrai M, Giannaccini G, Serra P, Lucacchini A, Cassano GB: Effect of aging and sex on the [3H]-paroxetine binding to human platelets. J Affect Disord 1998;50:11-15.
55. Cash R, Raisman R, Ploska A, Agid Y: High and low affinity [3H]-imipramine binding sites in control and parkinsonian brains. Eur J Pharmacol 1985;117:71-80.
56. Weizman R, Carmi M, Hermesh H, Shahar A, Apter A, Tyano S, Rehavi M: High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients. Am J Psychiatry 1986;143:335-339.
57. Marazziti D, Rotondo A, Placidi GF, Perugi G, Cassano GB, Pacifici GM: Binding of imipramine to platelet membranes is reduced in panic attacks. Fundam Clin Pharmacol 1988;2:69-75.
58. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Mueller CR, Hamer DH, Murphy DL: Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527-1531.
59. 11C]McN 5652. Am J Psychiatry 2005;162:915-923.